Analyst Ratings for Aktis Oncology (AKTS)
AKTS Rating Summary
AKTS Price Target Summary
- Highest: $40.00 (Raymond James)
- Lowest: $30.00 (JPMorgan)
- Average: $34.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$34.00 (+41.1%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 81%
Rating Score: 7.6 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/15/2026 | Raymond James | Christopher Raymond | New Coverage | Strong Buy (N/A) |
40.00 (N/A) |
21.93 (24.09) |
9.85% | Details |
| 4/29/2026 | William Blair | Alexandra Ramsey | New Coverage | Outperform (N/A) |
N/A (N/A) |
18.60 (24.09) |
29.52% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
